Medicare Enrolled
Dr. Vikas Malhotra, M.D.
Hematology · Spring Hill, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Malhotra from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Malhotra? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Malhotra
Dr. Vikas Malhotra is a hematology in Spring Hill, FL, with 20 years in practice. Based on federal Medicare data, Dr. Malhotra performed 397,025 Medicare services across 6,165 unique beneficiaries.
Between the years covered by Open Payments, Dr. Malhotra received a total of $58,431 from 100 pharmaceutical and/or device companies across 944 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Malhotra is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 2% volume in FL$ $58,431 industry payments
Medicare Practice Summary
Medicare Utilization ↗397,025
Medicare services
Top 2% in FL for hematology
6,165
Unique beneficiaries
$8
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~19,851 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron sucrose injection (Venofer) | 113,400 | $0 | $5 |
| Filgrastim injection (Nivestym) for white blood cells | 84,120 | $0 | $1 |
| Pembrolizumab injection (Keytruda) | 44,600 | $43 | $137 |
| Filgrastim injection (Zarxio) for white blood cells | 40,320 | $0 | $2 |
| Anti-nausea injection (aprepitant) | 20,280 | $1 | $5 |
| Oxaliplatin chemotherapy injection | 18,898 | $0 | $12 |
| Denosumab injection (Prolia/Xgeva) | 15,060 | $18 | $51 |
| Paclitaxel chemotherapy injection | 11,994 | $0 | $2 |
| Immune globulin infusion (Gammagard) | 10,170 | $36 | $108 |
| Epoetin alfa injection (Procrit) for anemia | 7,120 | $6 | $23 |
| Dexamethasone injection (steroid) | 4,540 | $0 | $3 |
| Complete blood count (CBC) with differential | 4,145 | $8 | $29 |
| Blood draw (venipuncture) | 3,928 | $8 | $9 |
| Anti-nausea injection (Aloxi/palonosetron) | 2,440 | $1 | $28 |
| Office visit, established patient (30-39 min) | 2,002 | $95 | $339 |
| Anti-nausea injection (ondansetron/Zofran) | 1,528 | $0 | $9 |
| Drug injection, under skin or into muscle | 1,469 | $10 | $69 |
| Administration of chemotherapy into vein, 1 hour or less | 788 | $97 | $378 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 755 | $47 | $189 |
| Injection of additional new drug or substance into vein | 731 | $12 | $61 |
| Infusion into a vein for hydration, each additional hour | 711 | $10 | $42 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 686 | $1 | $6 |
| Injection, leucovorin calcium, per 50 mg | 678 | $3 | $12 |
| Infusion, normal saline solution , 1000 cc | 593 | $2 | $7 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 585 | $22 | $84 |
| Office visit, established patient (20-29 min) | 540 | $62 | $239 |
| Injection, fluorouracil, 500 mg | 476 | $2 | $7 |
| Infusion into a vein for hydration, 31-60 minutes | 469 | $24 | $156 |
| Injection, carboplatin, 50 mg | 445 | $2 | $41 |
| Injection, diphenhydramine hcl, up to 50 mg | 345 | $1 | $3 |
| Injection, magnesium sulfate, per 500 mg | 318 | $1 | $2 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 310 | $15 | $56 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 265 | $1 | $7 |
| Administration of chemotherapy into vein, each additional hour | 246 | $21 | $79 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 226 | $17 | $59 |
| Injection, zoledronic acid, 1 mg | 220 | $7 | $69 |
| Administration of additional new drug or substance into vein, 1 hour or less | 219 | $49 | $178 |
| Office visit, established patient, complex (40-54 min) | 187 | $140 | $474 |
| Injection of drug or substance into vein | 163 | $28 | $156 |
| New patient office visit, complex (60-74 min) | 117 | $165 | $585 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 108 | $25 | $88 |
| Ceftriaxone antibiotic injection | 100 | $0 | $3 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 95 | $3 | $11 |
| Automated urinalysis | 93 | $2 | $8 |
| Injection, methylprednisolone sodium succinate, up to 125 mg | 87 | $4 | $15 |
| Prothrombin time test (blood clotting) | 70 | $4 | $15 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 68 | $15 | $56 |
| Administration of additional new drug or substance into vein using push technique | 68 | $41 | $170 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 66 | $131 | $562 |
| Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l | 60 | $124 | $637 |
| Smoking and tobacco use intensive counseling, 4-10 minutes | 58 | $15 | $41 |
| Red blood count automated, with additional calculations | 29 | $5 | $20 |
| Red blood count, automated test | 20 | $4 | $10 |
| Transitional care management services for problem of high complexity | 16 | $214 | $722 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
3.5% high complexity
93.5% medium
3.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$58,431
Total received (2018-2024)
Avg $8,347/year across 7 years
Top 9% in FL for hematology
100
Companies
944
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$35,017 (59.9%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,394 (21.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$11,021 (18.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$8,373
2023$5,905
2022$6,128
2021$9,429
2020$11,429
2019$10,841
2018$6,326
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$11,661
PFIZER INC.
$6,798
Celgene Corporation
$4,568
Janssen Biotech, Inc.
$3,391
Spectrum Pharmaceuticals Inc.
$3,120
CSL Behring
$3,085
BeiGene USA, Inc.
$2,977
Epizyme, Inc.,
$2,568
Karyopharm Therapeutics Inc.
$2,356
ABBVIE INC.
$1,903
AbbVie Inc.
$1,387
Coherus Biosciences Inc.
$1,088
CTI BioPharma Corp.
$1,017
E.R. Squibb & Sons, L.L.C.
$999
AVEO Pharmaceuticals, Inc.
$945
Novartis Pharmaceuticals Corporation
$944
Genentech USA, Inc.
$796
Merck Sharp & Dohme Corporation
$676
Amgen Inc.
$531
Lilly USA, LLC
$504
Seagen Inc.
$400
Incyte Corporation
$373
TESARO, Inc.
$354
Athenex Pharmaceutical Division, LLC
$350
Bayer HealthCare Pharmaceuticals Inc.
$335
GlaxoSmithKline, LLC.
$321
Astellas Pharma US Inc
$295
Eisai Inc.
$249
Takeda Pharmaceuticals U.S.A., Inc.
$248
Gilead Sciences, Inc.
$213
GENZYME CORPORATION
$213
Merck Sharp & Dohme LLC
$208
Novocure GmbH
$200
EMD Serono, Inc.
$192
Daiichi Sankyo Inc.
$156
COMSORT, Inc
$150
Clovis Oncology, Inc.
$139
SOBI, INC
$132
Ipsen Biopharmaceuticals, Inc
$130
SANOFI-AVENTIS U.S. LLC
$123
Janssen Pharmaceuticals, Inc
$122
Regeneron Healthcare Solutions, Inc.
$118
Seattle Genetics, Inc.
$115
Puma Biotechnology, Inc.
$103
Stemline Therapeutics Inc.
$96
Agios Pharmaceuticals, Inc.
$92
Mirati Therapeutics, Inc.
$82
Octapharma USA, Inc.
$82
Foundation Medicine, Inc.
$75
AbbVie, Inc.
$70
Deciphera Pharmaceuticals Inc.
$69
Aurobindo Pharma USA, Inc.
$57
Sumitomo Pharma America, Inc.
$54
Boehringer Ingelheim Pharmaceuticals, Inc.
$53
Heron Therapeutics, Inc.
$52
Rigel Pharmaceuticals, Inc.
$51
Taiho Oncology, Inc.
$50
MEDIVATION FIELD SOLUTIONS LLC
$45
INSYS Therapeutics Inc
$45
Pharmacosmos Therapeutics Inc.
$43
Array BioPharma Inc.
$42
Myriad Genetic Laboratories, Inc.
$37
Aveo Pharmaceuticals, Inc.
$35
PUMA BIOTECHNOLOGY, INC.
$34
JAZZ PHARMACEUTICALS INC.
$34
Jazz Pharmaceuticals Inc.
$34
AMAG Pharmaceuticals, Inc.
$33
Myovant Sciences Inc.
$31
TG THERAPEUTICS, INC.
$31
EISAI INC.
$27
Sun Pharmaceutical Industries Inc.
$25
Axonics, Inc.
$24
Shire North American Group Inc
$23
ImmunoGen, Inc.
$22
TerSera Therapeutics LLC
$22
Pharmacyclics LLC, An AbbVie Company
$21
Pharmacyclics LLC, an AbbVie Company
$21
ADC Therapeutics America, Inc.
$21
Servier Pharmaceuticals LLC
$20
PharmaEssentia USA Corporation
$20
G1 Therapeutics, Inc.
$20
Alnylam Pharmaceuticals Inc.
$19
Bayer Healthcare Pharmaceuticals Inc.
$18
Dova Pharmaceuticals
$18
MACROGENICS, INC.
$17
Genmab U.S., Inc.
$17
SERVIER PHARMACEUTICALS LLC
$17
TAIHO ONCOLOGY, INC.
$17
ARRAY BIOPHARMA INC
$16
Verastem, Inc.
$16
Exelixis Inc.
$15
Alexion Pharmaceuticals, Inc.
$15
Blueprint Medicines Corporation
$14
R-Pharm US LLC
$14
Global Blood Therapeutics, Inc.
$12
Kyowa Kirin, Inc.
$12
Acrotech Biopharma LLC
$12
Advanced Accelerator Applications
$12
EUSA Pharma (US) LLC
$12
Lexicon Pharmaceuticals, Inc.
$12
Top 3 companies account for 39.4% of total payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · ALIMTA · AUGTYRO · AYVAKIT · Abraxane · Alecensa · Aliqopa · Avastin · Axonics r-SNM System · BELEODAQ · BESREMI · BLENREP · BOSULIF · BRUKINSA · Bavencio · Braftovi · CABLIVI · CABOMETYX · CALQUENCE · CHANTIX · COSELA · CYRAMZA · Cinvanti · Copiktra · DARZALEX · DOPTELET · Doptelet · ELIQUIS · ELITEK · ELREXFIO · EMEND · ENHERTU · ERBITUX · ERLEADA · EVENITY · Elahere · Enhertu · Epkinly · Erivedge · Erleada · FASLODEX · FERAHEME · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · Folotyn · GAZYVA · GILOTRIF · GIVLAARI · Halaven · Hizentra · IBRANCE · IDHIFA · IMBRUVICA · IMFINZI · INFLECTRA · INJECTAFER · INLYTA · INQOVI · Idelvion · Imbruvica · Ixempra · JADENU · JAKAFI · JEMPERLI · JEVTANA · Jivi · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MARGENZA · MEKINIST · MONJUVI · MONOFERRIC · MVASI · MYRISK · Marqibo · NERLYNX · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OJJAARA · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Onivyde · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · Padcev · Perjeta · Pomalyst · Prolia · QINLOCK · REBLOZYL · RETEVMO · RYBREVANT · Revlimid · Rezlidhia · Rubraca · SARCLISA · SCEMBLIX · SOMATULINE DEPOT · SUSTOL · SUTENT · SYNDROS · Somatuline Depot · Stivarga · Sylvant · TAGRISSO · TALVEY · TASIGNA · TAZVERIK · TECENTRIQ · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tecentriq · Tibsovo · Trodelvy · UKONIQ · Ultomiris · VARUBI · VENCLEXTA · VERZENIO · VONJO · VOTRIENT · VPRIV · Venclexta · Vitrakvi · Vonjo · XALKORI · XARELTO · XGEVA · XPOVIO · XTANDI · Xermelo · Xofigo · Xtandi · YONSA · ZEJULA · ZEPZELCA · ZOLADEX · Zevalin · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (60%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 9% for hematology in FL.
Equivalent to $15 per 100 Medicare services performed
Geographic Context
Hematologys within 10 mi
14
Per 100K population
6.9
County median income
$63,193
Nearest hospital
SPRINGBROOK HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Malhotra is a mixed practice specialist, with above-average Medicare volume (top 2% in FL), and high industry engagement (consulting-driven, top 9%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Malhotra experienced with iron sucrose injection (venofer)?
Based on Medicare claims data, Dr. Malhotra performed 113,400 iron sucrose injection (venofer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Malhotra receive payments from pharmaceutical companies?
Yes. Dr. Malhotra received a total of $58,431 from 100 companies across 944 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Malhotra's costs compare to other hematologys in Spring Hill?
Dr. Malhotra's average Medicare payment per service is $8. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Malhotra) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematologys in Spring Hill
Browse hematologys in Spring Hill ranked by procedure volume and transparency data.
Highest volume
Top Hematologys in FL
Hematologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematologys in FL
Which FL hematologys receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC..
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology